Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Search

Celadon Pharmaceuticals PLC

CEL:JPJ
/
13.4
GBX
Professional, scientific & technical services

Description

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism. The Company’s facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company’s subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

Company Details

Incorporated
31 August 2018
Admission date
04/08/2025
Securities in Issue​
68.85m
Market Cap
£9.2m

Contact Details

E-Mail
info@celadonpharma.co.uk
Phone
+44 (0)203 150 0252
Address
71-75 Shelton Street,
London, England,
WC2H 9JQ,
United Kingdom

Company Snapshot

Status
Live
Price
13.4 GBX
Offer Interest
13 GBX
Trading
Continuous
Ticker
CEL:JPJ
Class
Ord
Settlement
CREST
Industry
Professional, scientific & technical services
Country
United Kingdom
Company Number
11545912
ISIN
GB00BDQYGP38
Currency
GBX

Trading Results

DateQuantityMid. Price
22/08/20256,44613.4
22/08/202598413.4

Management Information

James Short
James Short
Chief Executive Officer
Don Perrott
Don Perrott
Director

TRANSACTING ON JP JENKINS

‘Trading on JP Jenkins is done via a matched bargain facility, this means that on instruction from your ‘Broker’ we will endeavour to match your shares against other buyer(s) or seller(s) who are also looking to transact. Requests to trade are performed on an availability basis, should an instruction be cancelled, altered or amended in anyway by an instruction from your broker then it shall lose its active place in the queue and reset to the end of list. JP Jenkins receives orders from brokers electronically via a FIX message or should your broker not have a FIX connection to our platform via telephone. If you do not have a UK registered stockbroker you will find a list of brokers that we have worked with to download here. You will also find a list of UK brokers at the bottom of this page and their contact details should you need to appoint one. JP Jenkins can ONLY take instruction to transact from a UK-registered stockbroker and cannot offer investment advice into companies displayed on our website. If you are unsure about trading please consult a financial advisor or wealth manager to assist you in determining what is right for you

How to Trade​

Trading with JP Jenkins

Trading Instructions:
To buy and sell shares in this company via JP Jenkins, you will need to use a regulated UK stockbroker.

For a comprehensive list of brokers click here.

Over 40 UK brokers regularly connect with our platform.
If you are based overseas and are interested in participating then please contact us directly by emailing info@jpjenkins.com or by calling 0207 469 0937
Trades take place through our central counterparty partner. There is a fee of 1.5% of the transaction price which is charged to both buyers and sellers and a £25 transaction fee. Your broker may also apply charges.

Please note, when purchasing shares Stamp Duty Reserve Tax (“SDRT”) may be applicable.

How to Trade